1473 related articles for article (PubMed ID: 29144802)
1. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
Xie X; Li Q; Zhang L; Ren W
Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
Qing L; Wei R; Chan L; Xiaoya Z; Xin X
J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
[TBL] [Abstract][Full Text] [Related]
3. CORRELATION OF INCREASED SERUM ADIPSIN WITH INCREASED CARDIOVASCULAR RISKS IN ADULT PATIENTS WITH GROWTH HORMONE DEFICIENCY.
Wang Y; Zheng X; Xie X; Qian W; Zhang L; Ren W
Endocr Pract; 2019 May; 25(5):446-453. PubMed ID: 30657359
[No Abstract] [Full Text] [Related]
4. Lipid Accumulation Product: a Simple and Accurate Index for Predicting Metabolic Syndrome in Patients with Adult Growth Hormone Deficiency.
Chan L; Xue H; Xiaoya Z; Jiajia X; Wei R; Linman L; Qing L; Lan L
Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):220-4. PubMed ID: 27123781
[TBL] [Abstract][Full Text] [Related]
5. Dose-response association between Chinese visceral adiposity index and cardiovascular disease: a national prospective cohort study.
Ren Y; Hu Q; Li Z; Zhang X; Yang L; Kong L
Front Endocrinol (Lausanne); 2024; 15():1284144. PubMed ID: 38699393
[TBL] [Abstract][Full Text] [Related]
6. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study.
Gui J; Li Y; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
Front Public Health; 2023; 11():1073824. PubMed ID: 36875382
[TBL] [Abstract][Full Text] [Related]
7. SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.
Numan Ahmad M; Halim Haddad F
Nutr Hosp; 2015 Dec; 32(6):2701-9. PubMed ID: 26667723
[TBL] [Abstract][Full Text] [Related]
8. Comparison of novel visceral obesity indexes with traditional obesity measurements in predicting of metabolically unhealthy nonobese phenotype in hemodialysis patients.
Zhou C; Peng Y; Jiang W; Yuan J; Zha Y
BMC Endocr Disord; 2021 Dec; 21(1):244. PubMed ID: 34923974
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance using obesity and lipid-related indices and atherogenic index of plasma to predict metabolic syndrome in the adult sudanese population.
Mosad AS; Elfadil GA; Elhassan SH; Elbashir ZA; S A Husain NEO; Karar T; Elfaki EM
Niger J Clin Pract; 2023 May; 26(5):617-624. PubMed ID: 37357479
[TBL] [Abstract][Full Text] [Related]
10. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
11. Screening for a Simple and Effective Indicator of Insulin Resistance in Chinese Reproductive-Aged Women, with the Insulin Clamp Technique as a Reference.
Long J; Li L; Wang F; Yang G; Cheng W; Wei J; Chen M; Liu D
Metab Syndr Relat Disord; 2019 Oct; 17(8):423-429. PubMed ID: 31305214
[No Abstract] [Full Text] [Related]
12. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference.
Wan H; Wang Y; Xiang Q; Fang S; Chen Y; Chen C; Zhang W; Zhang H; Xia F; Wang N; Lu Y
Cardiovasc Diabetol; 2020 Jul; 19(1):118. PubMed ID: 32736628
[TBL] [Abstract][Full Text] [Related]
13. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
14. Association of adiposity indicators with cardiometabolic multimorbidity risk in hypertensive patients: a large cross-sectional study.
Dong T; Lin W; Zhou Q; Yang Y; Liu X; Chen J; Liu H; Zhang C
Front Endocrinol (Lausanne); 2024; 15():1302296. PubMed ID: 38577567
[TBL] [Abstract][Full Text] [Related]
15. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
16. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study.
Li Y; Gui J; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
Front Endocrinol (Lausanne); 2023; 14():1201132. PubMed ID: 37576971
[TBL] [Abstract][Full Text] [Related]
17. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Maciel PM; Reaven GM
Am J Med; 2014 Feb; 127(2):152-7. PubMed ID: 24462013
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of novel obesity- and lipid-related indices as predictors of abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.
Yin Q; Yan X; Cao Y; Zheng J
BMC Endocr Disord; 2022 Nov; 22(1):272. PubMed ID: 36348340
[TBL] [Abstract][Full Text] [Related]
19. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
[TBL] [Abstract][Full Text] [Related]
20. Application of Visceral Adiposity Index and Anthropometry to Identify Preclinical Atherosclerosis in Menopausal Status Women.
Tongdee P; Loyd RA; Winwan K; Nimkuntod P
J Med Assoc Thai; 2016 Oct; 99 Suppl 7():S30-5. PubMed ID: 29901383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
